TY - CHAP M1 - Book, Section TI - Abbreviations A1 - Padley, Anthony P. Y1 - 2024 N1 - T2 - Westmead Anaesthetic Manual, 5th Edition AB - Table Graphic Jump Location|Download (.pdf)|Print5-HT5-hydroxytryptamineABGarterial blood gasACassist controlACEangiotensin-converting enzymeACVassist control ventilationADPadenosine diphosphateAEDautomated external defibrillatorAFatrial fibrillationAFEamniotic fluid embolismAICDautomatic implantable cardioverter defibrillatorALSadvanced life support, amyotrophic lateral sclerosisAMLamyotrophic lateral sclerosisAPaccessory pathwayAPHantepartum haemorrhageAPOacute pulmonary oedemaAPTTor aPTT activated partial thromboplastin timeARBangiotensin II receptor blockerARDSacute respiratory distress syndromeARMartificial rupture of the membranesARNIangiotensin receptor-neprilysin inhibitorASaortic valve stenosisASDatrial septal defectASISanterior superior iliac spineASTaspartate aminotransferaseATLSadvanced trauma life supportAVMarterio-venous malformationAVNRTatrioventricular nodal re-entrant tachycardiaAVRTatrioventricular re-entrant tachycardiaBAEPsbrainstem auditory evoked potentialsBBBblood–brain barrierBEbase excessBIHbenign intracranial hypertensionBiPAPbi-level positive airway pressureBISbispectral index monitoring systemBLMbleomycinBLSbasic life supportBMSbare metal stentsBNPbrain natriuretic peptideBNPB-type natriuretic peptideBPBbrachial plexus blockBPFbronchopleural fistulaBSAbody surface areaCABGcoronary artery bypass graft(s)CADcoronary artery diseaseCAScoronary artery stentCAVMcerebral arterio-venous malformationCBDcannabidiolCCAcommon carotid arteryCCFcongestive cardiac failureCFcystic fibrosisCHDcongenital heart diseaseCICOCan’t intubate, can’t oxygenateCKcreatine kinaseCMVcontrolled mandatory ventilationCMVcytomegalovirusCNcyanideCOcardiac outputCOMTcatechol-O-methyl transferaseCOPDchronic obstructive pulmonary diseaseCOXcyclo-oxygenaseCPcervical plexusCPAPcontinuous positive airway pressureCPKcreatine phosphokinaseCPPcerebral perfusion pressureCPPcoronary perfusion pressureCrClcreatinine clearanceCRTcardiac resynchronisation therapyCSCaesarean sectionCSEcombined spinal epiduralCSFcerebrospinal fluidCSLcompound sodium lactateCUSACavitron ultrasonic surgical aspiratorCVAcerebrovascular accidentCVPcentral venous pressureCVScardiovascular systemCVSTcerebral venous sinus thrombosisDAPTdual antiplatelet therapyDCMdilated cardiomyopathyDESdrug-eluting stentsDICdisseminated intravascular coagulationDILVdouble inlet left ventricleDKAdiabetic ketoacidosisDLCOdiffusing capacity of lungs for carbon monoxideDLTdouble lumen tubeDMdiabetes mellitusDNdibucaine numberDORVdouble outlet right ventricleDTIdirect thrombin inhibitorDVT/PEdeep venous thrombosis/pulmonary embolusECGelectrocardiographyECMOextra corporeal membrane oxygenationEDSEhlers–Danlos syndromeEEGelectroencephalographEJVexternal jugular veinERextended releaseERSemergency response systemERVexpiratory reserve volumeESPerector spinae planeETendotrachealEXITex utero intrapartum treatmentFDPsfibrin degradation productsFEIBA-NFfactor VIII inhibitor bypassing activityFESfat embolism syndromeFFPfresh frozen plasmaFIBfascia iliaca blockFOforamen ovaleFOBfibre-optic bronchoscopeFONAfront of neck accessFRCfunctional respiratory capacityG6PDglucose-6-phosphate dehydrogenaseGAgeneral anaesthesiaGCSGlasgow coma scoreGFRglomerular filtration rateGTNglyceryl trinitratehhourHAEhereditary angioedemaHBheart blockHbChaemoglobin CHbEhaemoglobin EHbHhaemoglobin HHbShaemoglobin SHCMhypertrophic cardiomyopathyHFNChigh-flow nasal cannulaHFNO/high-flow nasal oxygen/HHShyperosmolar hyperglycaemic stateHITheparin-induced thrombocytopeniaHOCMhypertrophic obstructive cardiomyopathyIAPintra-abdominal pressureIBWideal body weightICinspiratory capacityIHDischaemic heart diseaseIJVinternal jugular veinIMintramuscularINRinternational normalised ratioIOintraosseousIOPintraocular pressureIRimmediate releaseIRVinspiratory reserve volumeITPimmune thrombocytopenic purpuraIUFRintrauterine fetal resuscitationIVintravenousIVCinferior vena cavaIVIGintravenous immunoglobulinIVTintracranial venous thrombosisJVPjugular venous pressureKCCTkaolin-cephalin clotting timeLAleft atriumLAlocal anaestheticLBBBleft bundle branch blockLDHlactate dehydrogenaseLFVliberation from ventilationLMAlaryngeal mask airwayLMWHlow-molecular-weight heparinLOClevel of consciousnessLORloss of resistanceLPlumbar punctureLQTSlong QT syndromeLRSlactated Ringer’s solutionLSOLaser Safety OfficerLVleft ventricleLVEFleft ventricular ejection fractionLVOTleft ventricular outflow tractMACminimum alveolar concentrationMAPmean arterial pressureMATmultifocal atrial tachycardiamaxmaximumMDmitochondrial diseaseMDmuscular dystrophyMELASmitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndromeMEPmotor evoked potentialMETmetabolic equivalent of taskMetHbmethaemoglobin, methaemoglobinaemiaMGmyasthenia gravisMHmalignant hyperthermiaMImyocardial infarctionminminuteMMRmasseter muscle rigidityMMSmediastinal mass syndromeMNDmotor neurone diseaseMRmagnetic resonanceMRmitral valve regurgitation, modified release (of drug)MRAmineral corticoid receptor antagonistMRImagnetic resonance imagingMSmitral valve stenosisMSmultiple sclerosisMTPmassive transfusion protocolMVminute ventilationMVPmitral valve prolapseNAnoradrenalineNBCAn-butyl cyanoacrylateNCTsnarrow complex tachycardiasNDNMBDnon-depolarising neuromuscular blocking drugNGTnasogastric tubeNIVnon-invasive ventilationNK1neurokinin-1NMBDsneuromuscular blocking drugsNMDAN-methyl-D-aspartateNMJneuromuscular junctionNMSneuroleptic malignant syndromeNOACnon-vitamin K oral anticoagulant drugNPPOnegative pressure pulmonary oedemaNSAIDnon-steroidal anti-inflammatory drugNSTEMInon-ST segment elevation myocardial infarctionNT-proBNPN-terminal-pro b-type natriuretic peptideOCPoral contraceptive pillOIosteogenesis imperfectaOLVone lung ventilationOSAobstructive sleep apnoeaPAFplatelet activating factorPAIplasminogen activator inhibitorPCApatient-controlled analgesiaPCCprothrombin complex concentratePCEApatient-controlled epidural anaesthesiaPCIpercutaneous coronary interventionPCVpressure-controlled ventilationPDParkinson’s diseasePDApatent ductus arteriosusPDEphosphodiesterasePDPHpost-dural puncture headachePEpulmonary embolismPEApulseless electrical activityPEEPpeak end expiratory pressurePEFRpeak expiratory flow ratePFOpatent foramen ovalePICCperipherally inserted central catheterPIEBprogrammed intermittent epidural bolusPIPpeak inspiratory pressurePONVpostoperative nausea and vomitingPOTSpostural orthostatic tachycardia syndromePPplacenta praeviaPPpulse pressurePPHpostpartum haemorrhagePplatplateau pressurePRVCpressure-regulated volume control mode ventilationPSpressure supportPSpulmonary stenosisPSVTparoxysmal supraventricular tachycardiaPTprothrombin timePTTpartial thromboplastin timePVpolycythaemia veraPVDpulmonary vascular disease or peripheral vascular disease, depending on contextPVRperipheral vascular resistancePVRpulmonary vascular resistanceqeveryRAright atriumRBBBright bundle branch blockRBCred blood cellsREresponse entropyRhRhesus factorRICrapid infusion catheterROSCreturn of spontaneous circulationRRrespiratory rateRSBIrapid shallow breathing indexRSIrapid sequence inductionrtPArecombinant tissue plasminogen activatorRVresidual volumeRVright ventricleRVOTright ventricular outflow tractssecondSAsinoatrial nodeSABsubarachnoid blockSAHsubarachnoid haemorrhageSANRTsinoatrial nodal re-entrant tachycardiaSBPsystolic blood pressureSBTspontaneous breathing trialSCDsickle cell diseaseSCMsternocleidomastoidSCTsickle cell traitSEstate entropySEMsystolic ejection murmurSFAsuperficial femoral arterySFVsuperficial femoral veinsGCsoluble guanylate cyclaseSGLT2sodium-glucose cotransporter-2SIADHsyndrome of inappropriate anti-diuretic hormone secretionSIMVsynchronous intermittent ... SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/09/18 UR - accessworldmed.mhmedical.com/content.aspx?aid=1208520468 ER -